Administration & Faculty

R. Brigg Turner, PharmD, BCPS

Assistant Professor

503-352-7288
brigg.turner@pacificu.edu

 

Education

2013 PGY-2 Infectious Diseases Pharmacy Residency

West Virginia University Healthcare

Morgantown, WV 

2012 PGY-1 Pharmacy Residency

West Virginia University Healthcare

Morgantown, WV 

2011 Doctor of Pharmacy

Lake Erie College of Osteopathic Medicine

Erie, PA 

2007 Bachelor of Science, Neuroscience

Brigham Young University

Provo UT 

 

Clinical Practice Site

Legacy Health, Emanuel Medical Center, Portland OR 

 

Teaching Courses

PHRM 681: Infectious Diseases I

PHRM 682: Infectious Diseases II

PHRM 686: Infectious Diseases III 

 

Areas of Research & Specialization

Interest areas include infectious diseases, antimicrobial resistance, antimicrobial stewardship, and pharmacokinetics/pharmacodynamics of antimicrobials 

 

Publications and Poster Presentations

Turner RB, Biondo L, Slain D, Phillips U, Cardenas S, Moffett K. A Randomized Pilot Study of Continuous Versus Intermittent Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis. Poster presented at the Annual North American Cystic Fibrosis Conference; Salt Lake City, UT: October 2013. 

Turner RB, Biondo L. Twice Daily Dosing of Tobramycin Improves Attainment of Pharmacokinetic Parameters in Pediatric Patients with Cystic Fibrosis. Poster presented at the Annual North American Cystic Fibrosis Conference; Salt Lake City, UT: October 2013. 

Kirk H, Turner RB, Sweet M, LaSala PR, Slain D, Khakoo R. Comparison of Methicillin-Resistant Staphylococcus aureus Contamination Rates of Medication Cabinets Between Isolation and Non-Isolation Rooms. Accepted for presentation at IDWeek 2013; San Francisco, CA: October 2013. 

Turner RB, Keller L, Slain D, Petros K, Sarwari A. Prolonged Infusion of Cephalosporins Did Not Improve Outcomes in Gram-Negative Infections in the Clinical Setting. Accepted for presentation at ICAAC 2013, American Society of Microbiology; Denver, CO: September 2013. 

Turner RB, Keller L, Slain D. Treatment of Vancomycin-Resistant Enterococci (VRE) Isolated from Urinary Samples. Poster presented at the Midyear Clinical Meeting, abstract [315029], American Society of Health-System Pharmacists; Las Vegas, NV: December 2012. 

Turner RB, Vroman B, Ulisse C, Mehta A, Corso T, Devi SS. Primed mice are protected from liver injury following a normally lethal dose of acetaminophen. Poster presented at the Annual Spring Meeting, Allegheny-Erie Society of Toxicology; Pittsburgh, Pennsylvania: April, 2010. 

Turner RB, Vagula M, Devi SS. Osteoporosis: an understated complication of diabetes. U.S. Pharmacist. May 2009(Diabetes suppl); 34(5):14-16.

 

 

Back to Administration & Faculty Listing